Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma.

Br J Cancer · 2013 · PMC3721396 · PMID 23799848

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the effect of Ron on EFS did not reach statistical significance, pEGFR and staging also did not reach statistical significance as independent predictors for worse EFS in this patient population, even though both are known prognostic factors ( Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.